Nuvation Bio Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Nuvation Bio Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2024.
  • Nuvation Bio Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$41.2M, a 110% decline year-over-year.
  • Nuvation Bio Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$975M, a 1077% decline year-over-year.
  • Nuvation Bio Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$519M, a 398% decline from 2022.
  • Nuvation Bio Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$104M, a 20% decline from 2021.
  • Nuvation Bio Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$86.8M, a 108% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$975M -$41.2M -$21.6M -110% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 -$954M -$462M -$442M -2141% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-06
Q1 2024 -$512M -$14.8M +$6.93M +31.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-06
Q4 2023 -$519M -$457M -$436M -2092% Oct 1, 2023 Dec 31, 2023 8-K/A 2024-06-20
Q3 2023 -$82.9M -$19.6M +$7.55M +27.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$90.4M -$20.6M +$14.2M +40.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-06
Q1 2023 -$105M -$21.7M -$433K -2.03% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-06
Q4 2022 -$104M -$20.8M +$4.29M +17.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$108M -$27.2M -$5.22M -23.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$103M -$34.9M -$15.5M -80.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-02
Q1 2022 -$87.7M -$21.3M -$891K -4.37% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-02
Q4 2021 -$86.8M -$25.1M -$11.9M -89.3% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 -$75M -$22M -$10.9M -99.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$64M -$19.3M -$10.7M -125% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-03
Q1 2021 -$53.3M -$20.4M -$11.7M -133% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-03
Q4 2020 -$41.7M -$13.3M Oct 1, 2020 Dec 31, 2020 10-K 2022-02-28
Q3 2020 -$11M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$8.6M Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$8.75M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.